Health TidingsOno Files VELEXBRU Expansion in Japan for Secondary CNS Lymphoma Ono Files VELEXBRU Expansion in Japan for Secondary CNS Lymphoma Read Post »
New Drug ApprovalFDA Expands Organon’s TOFIDENCE Biosimilar Approval to CAR-T CRS and COVI... FDA Expands Organon’s TOFIDENCE Biosimilar Approval to CAR-T CRS and COVI... Read Post »
Drugs Safety AlertFDA Updates Alli Label to Warn of Rare Risk of Acute Kidney Injury and Kidn... FDA Updates Alli Label to Warn of Rare Risk of Acute Kidney Injury and Kidn... Read Post »
Health TidingsWhat Zepbound and Shaquille O’Neal’s Story Reveal About Undiagn... What Zepbound and Shaquille O’Neal’s Story Reveal About Undiagn... Read Post »
Health TidingsEMA Begins Review of Bayer’s Asundexian for Secondary Stroke Prevention EMA Begins Review of Bayer’s Asundexian for Secondary Stroke Prevention Read Post »
Clinical TrialsSanofi Halts Phase 3 MOBILIZE Trial of Riliprubart in Refractory CIDP Sanofi Halts Phase 3 MOBILIZE Trial of Riliprubart in Refractory CIDP Read Post »
Health TidingsFDA Accepts Takeda’s ENTYVIO sBLA for Pediatric Ulcerative Colitis and Cr... FDA Accepts Takeda’s ENTYVIO sBLA for Pediatric Ulcerative Colitis and Cr... Read Post »
Health TidingsBausch Health Secures Key Reimbursement Milestone for PrOKEDI in Canada Bausch Health Secures Key Reimbursement Milestone for PrOKEDI in Canada Read Post »
Health Tidings Mergers & AcquisitionsLilly Signs Potential $1 Billion Alzheimer’s Deal With AlzeCure Lilly Signs Potential $1 Billion Alzheimer’s Deal With AlzeCure Read Post »
Clinical TrialsFDA Aligns on Phase 3 Design for Alterity’s ATH434 in MSA FDA Aligns on Phase 3 Design for Alterity’s ATH434 in MSA Read Post »
New Drug ApprovalFDA Approves Every-8-Week EBGLYSS Dosing for Atopic Dermatitis FDA Approves Every-8-Week EBGLYSS Dosing for Atopic Dermatitis Read Post »
New Drug ApprovalFDA Adds Bemotrizinol to OTC Sunscreen Monograph, First New UV Filter in Ov... FDA Adds Bemotrizinol to OTC Sunscreen Monograph, First New UV Filter in Ov... Read Post »
Health TidingsTeva Presents New AUSTEDO Data Across the Tardive Dyskinesia Care Continuum Teva Presents New AUSTEDO Data Across the Tardive Dyskinesia Care Continuum Read Post »
Health TidingsNMPA Approves TIVDAK for Recurrent or Metastatic Cervical Cancer NMPA Approves TIVDAK for Recurrent or Metastatic Cervical Cancer Read Post »
Clinical TrialsTango Sets Phase 3 Course for Vopimetostat-Daraxonrasib in MTAP-Deleted PDA... Tango Sets Phase 3 Course for Vopimetostat-Daraxonrasib in MTAP-Deleted PDA... Read Post »
New Drug ApprovalMHRA Grants Authorization for Nipocalimab in gMG MHRA Grants Authorization for Nipocalimab in gMG Read Post »
Clinical Trials82% of Patients Respond to BRIUMVI in Early Myasthenia Gravis Study 82% of Patients Respond to BRIUMVI in Early Myasthenia Gravis Study Read Post »
Clinical TrialsGilead and Merck’s Once-Weekly HIV Pill Meets Phase 3 Goals Gilead and Merck’s Once-Weekly HIV Pill Meets Phase 3 Goals Read Post »
Health Tidings Mergers & AcquisitionsGSK Acquires Nuvalent, Adding FDA-Reviewed ROS1 and ALK Inhibitors GSK Acquires Nuvalent, Adding FDA-Reviewed ROS1 and ALK Inhibitors Read Post »
Health TidingsMerck and Gilead Halt Phase 3 KEYNOTE-D46/EVOKE-03 Study Over Missing PFS E... Merck and Gilead Halt Phase 3 KEYNOTE-D46/EVOKE-03 Study Over Missing PFS E... Read Post »
Clinical TrialsLilly’s Oral GLP-1 Foundayo Shows Clear Edge Over Oral Semaglutide Lilly’s Oral GLP-1 Foundayo Shows Clear Edge Over Oral Semaglutide Read Post »
Mergers & AcquisitionsJohnson & Johnson Acquires Firefly Bio in $1 Billion Oncology Deal Johnson & Johnson Acquires Firefly Bio in $1 Billion Oncology Deal Read Post »
Health TidingsUK Clears Moderna’s mRNA-4194 for Lynch Syndrome Cancer Prevention Study UK Clears Moderna’s mRNA-4194 for Lynch Syndrome Cancer Prevention Study Read Post »
Clinical TrialsElecoglipron Lowers HbA1c by 1.9% and Drives Weight Loss in Phase 2b Studie... Elecoglipron Lowers HbA1c by 1.9% and Drives Weight Loss in Phase 2b Studie... Read Post »
Clinical TrialsSurvodutide Delivers Up to 16.6% Weight Loss and Reduces Liver Fat in Phase... Survodutide Delivers Up to 16.6% Weight Loss and Reduces Liver Fat in Phase... Read Post »
Health Tidings Mergers & AcquisitionsRoche Licenses Nurix’s BTK Degrader Bexobrutideg in Up to $2.3 Billion De... Roche Licenses Nurix’s BTK Degrader Bexobrutideg in Up to $2.3 Billion De... Read Post »
Health Tidings Mergers & AcquisitionsIncyte Bolsters Hematology Growth With $2 Billion Vega Buyout Incyte Bolsters Hematology Growth With $2 Billion Vega Buyout Read Post »
Health TidingsKorlym Cuts HbA1c and Weight in Difficult-to-Control Diabetes Linked to Hyp... Korlym Cuts HbA1c and Weight in Difficult-to-Control Diabetes Linked to Hyp... Read Post »
ResearchINGREZZA Delivered Rapid Tardive Dyskinesia Improvement in Patients With ID... INGREZZA Delivered Rapid Tardive Dyskinesia Improvement in Patients With ID... Read Post »
Clinical TrialsCullinan Therapeutics Delivers CLN-978 Remission in Lupus and RA Cullinan Therapeutics Delivers CLN-978 Remission in Lupus and RA Read Post »
Clinical TrialsCagriSema Delivers Superior HbA1c and Weight Reduction Across Phase 3 REIMA... CagriSema Delivers Superior HbA1c and Weight Reduction Across Phase 3 REIMA... Read Post »
Health TidingsFDA Review Accepted for Alvotech’s Vedolizumab Biosimilar FDA Review Accepted for Alvotech’s Vedolizumab Biosimilar Read Post »
New Drug ApprovalEU Approves Sarclisa On-Body Injector Option for Multiple Myeloma EU Approves Sarclisa On-Body Injector Option for Multiple Myeloma Read Post »
New Drug ApprovalFDA Approves HYMPAVZI for Children and Hemophilia Patients With Inhibitors FDA Approves HYMPAVZI for Children and Hemophilia Patients With Inhibitors Read Post »
Health TidingsMazdutide Achieves 18.6% Weight Loss in Adults With Obesity Mazdutide Achieves 18.6% Weight Loss in Adults With Obesity Read Post »
Health TidingsFoundayo Shows Consistent Weight Loss Across Menopause Stages in Phase 3 AT... Foundayo Shows Consistent Weight Loss Across Menopause Stages in Phase 3 AT... Read Post »
Clinical TrialsMazdutide Extends Lead Over Semaglutide in Detailed DREAMS-3 Results Mazdutide Extends Lead Over Semaglutide in Detailed DREAMS-3 Results Read Post »
Clinical TrialsSemaglutide Cuts Sleep Apnea Risk and Improves Cardiometabolic Health in Ne... Semaglutide Cuts Sleep Apnea Risk and Improves Cardiometabolic Health in Ne... Read Post »
Clinical TrialsRepatha Cuts Cardiovascular Events by 29% in High-Risk Diabetes Subgroup Repatha Cuts Cardiovascular Events by 29% in High-Risk Diabetes Subgroup Read Post »
Health TidingsNYB.AI Featured in NVIDIA GTC Taiwan 2026 Opening Showcase, Marking Milesto... NYB.AI Featured in NVIDIA GTC Taiwan 2026 Opening Showcase, Marking Milesto... Read Post »
Clinical TrialsRetatrutide Delivers Up to 28.3% Weight Loss and Improves Obesity-Related C... Retatrutide Delivers Up to 28.3% Weight Loss and Improves Obesity-Related C... Read Post »
Health TidingsStructure Reports Up to 16.2% Weight Loss With Oral GLP-1 Aleniglipron Structure Reports Up to 16.2% Weight Loss With Oral GLP-1 Aleniglipron Read Post »
Clinical TrialsAmneal Reports Positive Interim Result for CREXONT® in PD Amneal Reports Positive Interim Result for CREXONT® in PD Read Post »
Clinical TrialsNovo Nordisk Reports Strong Real-World Outcomes With Semaglutide 2 mg Escal... Novo Nordisk Reports Strong Real-World Outcomes With Semaglutide 2 mg Escal... Read Post »
Health TidingsVertex Reports Strong ALYFTREK Results in Young Children With Cystic Fibros... Vertex Reports Strong ALYFTREK Results in Young Children With Cystic Fibros... Read Post »
Health TidingsTeva Reports Quality-of-Life Benefits With AUSTEDO in HD Chorea Teva Reports Quality-of-Life Benefits With AUSTEDO in HD Chorea Read Post »
Clinical TrialsPfizer’s Berobenatide Delivers Up to 15.9% Weight Loss, Supports Broa... Pfizer’s Berobenatide Delivers Up to 15.9% Weight Loss, Supports Broa... Read Post »
Health TidingsSouth Africa Rolls Out Lenacapavir to Prevent HIV South Africa Rolls Out Lenacapavir to Prevent HIV Read Post »
Clinical TrialsAstraZeneca Reports Positive Phase III Results for Ultomiris in IgAN AstraZeneca Reports Positive Phase III Results for Ultomiris in IgAN Read Post »
Clinical TrialsMannKind Reports New Afrezza Findings Across Pediatric and Adult Diabetes P... MannKind Reports New Afrezza Findings Across Pediatric and Adult Diabetes P... Read Post »
